India, Aug. 27 -- Xtant Medical Holdings, Inc. (XTNT), a medical technology company focused on surgical solutions for the treatment of spinal, orthopaedic, and wound care disorders, announced an exclusive partnership with BioHorizons, under which BioHorizons will distribute Xtant's allogeneic growth factor technology, OsteoFactor Pro, under the private brand Prolifica through its commercial network.
The agreement represents BioHorizons as the exclusive distributor of Xtant's allogeneic growth factor technology into the dental and oral-maxillofacial procedure markets in the United States and Canada.
The deal combines Xtant's regenerative medicine development and manufacturing capabilities with BioHorizons' commercial reach and customer rel...